A Quarter 3 research report by Counterpoint Research ranks the previous year’s iPhone 13 as the best-selling in India. It is because it is the first time an iPhone has dominated other rival smartphones in India. Furthermore, Q3 has seen a decrease in overall mobile phone orders.
But on a larger scale, the rest of the shipments declined.
The iPhone 13 is being hailed as the bestseller for this year in India. Still, it’s not just limited to the U.S. Apple also took the lead in its premium category with a 40% share, followed by Samsung and OnePlus. In April, the iPhone 13 was also on top of the global bestsellers list.
The latest numbers for Q3 2022 show an 11% decline in overall shipments from last year to 54 million units. This figure is much lower than expected due to many different factors, one of which is that demand for entry-level and budget phones decreased. All brands are impacted, but this phone category had the lowest sales.
(Also see: iPhone 14 vs iPhone 13 Full Specs Comparison)
The handset market saw a 15% drop in revenue due to an economic downturn. The market for feature phones dipped by 24% “due to adverse macroeconomic conditions.“
The OPPO was the fastest-growing brand in the top five. Although, its shipments declined by 19%. The report suggests that the budget segment had lower demand while the mid-tier helped them maintain their first position. Samsung took the second spot with 19% and became the fastest-growing brand in the top five. It was followed by Vivo (14%), Realme (also 14%), and Xiaomi (21%). The first phone of Nothing could not manage to have a mid-share or a share in the premium tier market.
Since the official 5G rollout, many people have become more eager to invest in the newest phones. Xiaomi became the top 5G smartphone brand in Q3 of 2022 in the sub-Rs 20,000 range.
According to Counterpoint Research’s Senior Research Analyst Prachir Singh, we will see a demand uptick during the year-end sales. It remains to be seen what Q4’s report will reveal. In the meantime, share your thoughts on the Q3 findings in the comments below.
Sourec: Counterpoint Research
